AB Science: New publication on medrxiv demonstrating substantial survival benefits and preserved quality of life with masitinib in ALS patients
Summary
PRESS RELEASE
Description
PRESS RELEASE
Original reporting
AFBytes is a read-only aggregator. Use the original source for full context and complete reporting.
Open original source